Bradley L. Ackermann

Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

Steven A. Carr, Susan E. Abbatiello, Bradley L. Ackermann et al. · Molecular & Cellular Proteomics · 2014 · 557 citations · Full text

Life Sciences, Biochemistry, Analytical Chemistry +16

In Vitro Glucuronidation Using Human Liver Microsomes and The Pore-Forming Peptide Alamethicin

Michael B. Fisher, Kristina Campanale, Bradley L. Ackermann et al. · Drug Metabolism and Disposition · 2000 · 342 citations

Life Sciences, Biochemistry, Pharmacology +14

Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites.

R. Poulin, Li‐Fan Lu, Bradley L. Ackermann et al. · Journal of Biological Chemistry · 1992 · 217 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Surrogate Matrix And Surrogate Analyte Approaches For Definitive Quantitation of Endogenous Biomolecules

Barry Jones, Gary A. Schultz, James A. Eckstein et al. · Bioanalysis · 2012 · 183 citations

Pharmacy, Biochemistry, Analytical Toxicology +15

Quantitative analysis of amyloid <i>β</i> peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry

Tomoyuki Oe, Bradley L. Ackermann, Kōichi Inoue et al. · Rapid Communications in Mass Spectrometry · 2006 · 166 citations

Life Sciences, Biochemistry, Neuroscience +17